Barbanti, P.; Orlando, B.; Egeo, G.; d’Onofrio, F.; Doretti, A.; Messina, S.; Autunno, M.; Messina, R.; Filippi, M.; Fiorentini, G.;
et al. Evaluating the Effectiveness, Tolerability, and Safety of Eptinezumab in High-Frequency and Chronic Migraine in Real World: EMBRACE—The First Italian Multicenter, Prospective, Real-Life Study. Brain Sci. 2024, 14, 672.
https://doi.org/10.3390/brainsci14070672
AMA Style
Barbanti P, Orlando B, Egeo G, d’Onofrio F, Doretti A, Messina S, Autunno M, Messina R, Filippi M, Fiorentini G,
et al. Evaluating the Effectiveness, Tolerability, and Safety of Eptinezumab in High-Frequency and Chronic Migraine in Real World: EMBRACE—The First Italian Multicenter, Prospective, Real-Life Study. Brain Sciences. 2024; 14(7):672.
https://doi.org/10.3390/brainsci14070672
Chicago/Turabian Style
Barbanti, Piero, Bianca Orlando, Gabriella Egeo, Florindo d’Onofrio, Alberto Doretti, Stefano Messina, Massimo Autunno, Roberta Messina, Massimo Filippi, Giulia Fiorentini,
and et al. 2024. "Evaluating the Effectiveness, Tolerability, and Safety of Eptinezumab in High-Frequency and Chronic Migraine in Real World: EMBRACE—The First Italian Multicenter, Prospective, Real-Life Study" Brain Sciences 14, no. 7: 672.
https://doi.org/10.3390/brainsci14070672
APA Style
Barbanti, P., Orlando, B., Egeo, G., d’Onofrio, F., Doretti, A., Messina, S., Autunno, M., Messina, R., Filippi, M., Fiorentini, G., Rotondi, C., Bonassi, S., & Aurilia, C.
(2024). Evaluating the Effectiveness, Tolerability, and Safety of Eptinezumab in High-Frequency and Chronic Migraine in Real World: EMBRACE—The First Italian Multicenter, Prospective, Real-Life Study. Brain Sciences, 14(7), 672.
https://doi.org/10.3390/brainsci14070672
